Puzo Michael J Novo Nordisk A S Transaction History

Puzo Michael J

$363 Million
Q3 2025

A detailed history of Puzo Michael J transactions in Novo Nordisk A S stock. As of the latest transaction made, Puzo Michael J holds 5,775 shares of NVO stock, worth $279,856. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,775

Previous 43,933 86.85%

Holding current value

$279,856

Previous $3.03 Million 89.45%

% of portfolio

0.09%

Previous 0.88%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$45.38 - $71.7 $1.73 Million - $2.74 Million	-38,158 Reduced 86.85%	5,775 $320,000
Q2 2025 Jul 23, 2025	BUY	$58.08 - $81.05 $1.13 Million - $1.57 Million	19,383 Added 78.95%	43,933 $3.03 Million
Q1 2025 Apr 18, 2025	BUY	$69.3 - $90.95 $1.32 Million - $1.73 Million	19,050 Added 346.36%	24,550 $1.7 Million
Q4 2024 Feb 12, 2025	BUY	$85.0 - $120.04 $42,500 - $60,020	500 Added 10.0%	5,500 $473,000
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $12,271 - $14,691	-100 Reduced 1.96%	5,000 $713,000

Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $61,266 - $81,551	-600 Reduced 10.53%	5,100 $654,000
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $149,226 - $179,265	-1,700 Reduced 22.97%	5,700 $589,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $272,820 - $598,620	3,000 Added 68.18%	7,400 $672,000
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $92,638 - $111,397	-700 Reduced 13.73%	4,400 $700,000
Q3 2022 Nov 08, 2022	SELL	$95.28 - $116.93 $47,640 - $58,465	-500 Reduced 8.93%	5,100 $509,000
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $36,134 - $42,633	-350 Reduced 5.88%	5,600 $624,000
Q1 2022 May 17, 2022	SELL	$93.1 - $112.54 $23,275 - $28,135	-250 Reduced 4.03%	5,950 $660,000
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $105,468 - $128,788	1,100 Added 21.57%	6,200 $694,000
Q3 2021 Nov 10, 2021	SELL	$84.42 - $106.62 $33,768 - $42,648	-400 Reduced 7.27%	5,100 $490,000
Q3 2020 Oct 28, 2020	SELL	$63.69 - $70.22 $50,952 - $56,176	-800 Reduced 12.7%	5,500 $382,000
Q2 2020 Jul 28, 2020	SELL	$58.54 - $67.94 $11,708 - $13,588	-200 Reduced 3.08%	6,300 $412,000
Q1 2020 May 07, 2020	SELL	$49.46 - $64.78 $9,892 - $12,956	-200 Reduced 2.99%	6,500 $391,000
Q4 2018 Jan 24, 2019	SELL	$41.54 - $47.25 $93,465 - $106,312	-2,250 Reduced 25.14%	6,700 $308,000
Q3 2018 Oct 15, 2018	SELL	$46.76 - $51.24 $32,732 - $35,868	-700 Reduced 7.25%	8,950 $422,000
Q2 2018 Jul 30, 2018	SELL	$44.29 - $50.42 $17,716 - $20,168	-400 Reduced 3.98%	9,650 $446,000
Q1 2018 Apr 24, 2018	SELL	$48.49 - $58.14 $123,649 - $148,257	-2,550 Reduced 20.24%	10,050 $495,000
Q4 2017 Feb 02, 2018	BUY	$47.53 - $53.73 $190,120 - $214,920	4,000 Added 46.51%	12,600 $677,000
Q3 2017 Oct 26, 2017	BUY	$41.15 - $49.22 $353,890 - $423,292	8,600	8,600 $414,000

Others Institutions Holding NVO

# of Institutions

1,698

Shares Held

303M

Call Options Held

27.9M

Put Options Held

44.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.

Account